hCG for TRT
Human Chorionic Gonadotropin, Preserving Testicular Function and Fertility on Testosterone
Evidence grade 3 of 5, Mixed. Read how the Atlas grades evidence.
The written rationale for this grade is still being prepared.
- FDA
- FDA-approved for hypogonadotropic hypogonadism and other indications; fertility-preservation use alongside TRT is off-label
Reference only. Not medical advice.
This is something to take to a clinician. The Atlas can tell you what is known about hcg for trt in general. It cannot tell you what is happening in your body, and the difference matters most for exactly the symptoms that bring people to this page.
Human chorionic gonadotropin (hCG) mimics luteinizing hormone, directly stimulating Leydig cells to maintain intratesticular testosterone and spermatogenesis. Because exogenous testosterone suppresses LH and FSH, hCG is used adjunctively to counter testicular atrophy and help preserve fertility on TRT, or as monotherapy to stimulate endogenous production. Its use alongside TRT is off-label.
The LH stand-in that keeps the testes working while testosterone shuts the signal off.
What people take it for
These are the reasons people give for taking it. They are not effects it has been shown to have.
How it is supposed to work
hCG binds the LH receptor on Leydig cells, driving intratesticular testosterone production and supporting the high local testosterone concentration that spermatogenesis requires. When added to TRT, which suppresses pituitary LH/FSH, hCG substitutes for the missing LH signal, helping maintain testicular size and sperm production that exogenous testosterone alone would shut down.
Safety in detail
This intervention requires physician evaluation and monitoring; off-label combination regimens should not be self-administered. Changes to hormones, sexual function, or sexual health warrant evaluation by a qualified healthcare provider.
What it does to fertility
hCG is specifically used to counter the fertility-suppressing effect of TRT by maintaining intratesticular testosterone and spermatogenesis. It can help preserve or recover fertility but does not fully replace FSH signaling, so outcomes vary; some protocols add FSH-containing therapy when sperm production must be restored.
What has to be monitored
The bloodwork this needs, and the reason it belongs with a clinician rather than a website.
- Total testosterone and estradiol (hCG can raise estradiol)
- Semen analysis when fertility is the goal
- Testicular exam / volume assessment
- Hematocrit (combined regimens still affect erythropoiesis)
What people get wrong
Often saidhCG fully protects fertility on TRT
ActuallyhCG mitigates but does not guarantee preservation of fertility; FSH is still suppressed and results vary. Men with active fertility goals are often better served by avoiding TRT and using enclomiphene/clomiphene or nasal testosterone.
Who profits, and who pushes back
Nobody is named here yet, because we have not done that work on this entry. Read that as unfinished. Somebody almost certainly sells this, and somebody almost certainly disputes it. Assume both until we have checked.
At a glance
- Acts like
- Luteinizing hormone (LH)
- Target
- Leydig cells
- Goal on TRT
- Preserve testicular size and fertility
- Route
- Subcutaneous/IM injection
What this entry does not yet cover
What follows is unfinished work on our side, not a finding about hCG for TRT. A short entry is not a safe entry.
- Timeline. We have not built the dated record of research and regulatory events.
- Cost and market. We have not documented what it sells for or who sells it.
- Supply chain. We have not mapped where it is made.
- Who uses it. We have not documented the user groups.
- What could change. No forward-looking summary yet.
- How it compares. We have not set it against the alternatives.
- Children and teenagers. We have not checked what is known about younger people.
- What can go wrong. We have not written the risk line for this one. Read the safety section below rather than treating its absence as reassurance.
- Where we land. We have not taken a position on this yet.
Sources
The studies below are named and described, but not linked. You cannot open them from here and check our reading against them, which means this page is our summary of the literature rather than a document you can verify. Weigh it accordingly until the links exist.
The studies that matter
Low-dose hCG with testosterone (Coviello et al. and subsequent series)2005 onward
Concurrent low-dose hCG maintained intratesticular testosterone and helped preserve spermatogenesis in men on exogenous testosterone, supporting its adjunctive fertility-preservation role